This inventor holds 1 USPTO granted patent. Top assignee: Vtv Therapeutics LLC. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of Juan Hu
Introduction
Juan Hu is a prominent inventor based in Suzhou, China. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address critical health issues. Her work is characterized by a focus on innovative solutions for RAGE mediated diseases.
Latest Patents
Juan Hu holds a patent for pharmaceutically acceptable salts of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethylamine. This compound, referred to as 'COMPOUND I', is particularly useful in the treatment of diseases mediated by the receptor for advanced glycation end products (RAGE). Her patent reflects her commitment to advancing medical science and improving patient outcomes.
Career Highlights
Throughout her career, Juan Hu has demonstrated a strong dedication to research and innovation. She is currently associated with Vtv Therapeutics LLC, where she continues to explore new therapeutic avenues. Her work has not only contributed to her personal achievements but has also advanced the field of pharmaceutical sciences.
Collaborations
[This section has been skipped.]
Conclusion
Juan Hu's contributions to the field of pharmaceuticals through her innovative patents highlight her role as a leading inventor. Her work continues to pave the way for advancements in the treatment of complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile